These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4162539)

  • 1. Portacaval transposition in the treatment of glycogen-storage disease.
    Riddell AG; Davies RP; Clark AD
    Lancet; 1966 Nov; 2(7474):1146-8. PubMed ID: 4162539
    [No Abstract]   [Full Text] [Related]  

  • 2. Portacaval shunt in siblings for type I glycogenosis.
    Liebschutz D; Soper RT
    J Pediatr Surg; 1976 Aug; 11(4):557-61. PubMed ID: 823318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portacaval shunt in the treatment of glycogen storage disease: report of a case.
    Hermann RE; Mercer RD
    Surgery; 1969 Mar; 65(3):499-503. PubMed ID: 5250067
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgical therapy of glycogen storage disease.
    Boley SJ; Cohen MI; Gliedman ML
    Pediatrics; 1970 Dec; 46(6):929-33. PubMed ID: 5275633
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycogen storage disease treated by portacaval transposition.
    Ridell AG; Davies RP
    Proc R Soc Med; 1966 Jun; 59(6):484. PubMed ID: 5220251
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and biochemical findings before and after portacaval shunt in a girl with type Ib glycogen storage disease.
    Corbeel L; Hue L; Lederer B; De Barsy T; Van den Berghe G; Devlieger H; Jaeken J; Bracke P; Eeckels R
    Pediatr Res; 1981 Jan; 15(1):58-61. PubMed ID: 6259580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal diversion for the treatment of glycogen storage disease in humans.
    Starzl TE; Putnam CW; Porter KA; Halgrimson CG; Corman J; Brown BI; Gotlin RW; Rodgerson DO; Greene HL
    Ann Surg; 1973 Oct; 178(4):525-39. PubMed ID: 4517839
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term follow-up of portacaval shunt in glycogen storage disease type 1B.
    Corbeel L; Van Lierde S; Jaeken J
    Eur J Pediatr; 2000 Apr; 159(4):268-72. PubMed ID: 10789932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portacaval shunt for glycogen storage disease and hyperlipidaemia.
    Starzl TE; Putnam CW; Porter KA; Benichou J
    Ciba Found Symp; 1977; (55):311-25. PubMed ID: 207496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mixed variant of portal circulation block in a 10-year-old child].
    Tuĭchibekov ShM; Potapova-Vinogradova IN; Leont'ev AF
    Pediatriia; 1983 Oct; (10):72-3. PubMed ID: 6657362
    [No Abstract]   [Full Text] [Related]  

  • 11. Reappraisal of the Role of Portacaval Shunting in the Growth of Patients With Glycogen Storage Disease Type I in the Era of Liver Transplantation.
    Choi Y; Yi NJ; Ko JS; Moon JS; Suh SW; Lee JM; Jeong JH; Kim H; Lee HW; Lee KW; Suh KS
    Transplantation; 2016 Mar; 100(3):585-92. PubMed ID: 26360666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal diversion in glycogen storage disease.
    Starzl TE; Brown BI; Blanchard H; Brettschneider L
    Surgery; 1969 Mar; 65(3):504-6. PubMed ID: 4303854
    [No Abstract]   [Full Text] [Related]  

  • 13. [Portal shunts in metabolic liver diseases].
    Bismuth H; Franco D; Grange D
    Gastroenterol Clin Biol; 1977; 1(11):903-16. PubMed ID: 340317
    [No Abstract]   [Full Text] [Related]  

  • 14. Haematological findings in type Ib glycogen storage disease before and after portacaval shunt.
    Corbeel L; Boogaerts M; Van den Berghe G; Everaerts MC; Marchal G; Eeckels R
    Eur J Pediatr; 1983; 140(3):273-5. PubMed ID: 6578929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE EFFECT OF PORTACAVAL TRANSPOSITION ON CARBOHYDRATE METABOLISM: EXPERIMENTAL AND CLINICAL OBSERVATIONS.
    STARZL TE; MARCHIORO TL; SEXTON AW; ILLINGWORTH B; WADDELL WR; FARIS TD; HERRMANN TJ
    Surgery; 1965 May; 57():687-97. PubMed ID: 14295780
    [No Abstract]   [Full Text] [Related]  

  • 16. Should temporary extracorporeal continuous portal diversion replace meso/porta-caval shunts in "small-for-size" syndrome in porcine hepatectomy?
    Wang DD; Xu Y; Zhu ZM; Tan XL; Tu YL; Han MM; Tan JW
    World J Gastroenterol; 2015 Jan; 21(3):888-96. PubMed ID: 25624722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of partial portacaval transposition on the canine liver.
    Marchioro TL; Porter KA; Brown BI; Otte JB; Starzl TE
    Surgery; 1967 May; 61(5):723-32. PubMed ID: 4290396
    [No Abstract]   [Full Text] [Related]  

  • 18. [Physiopathologic bases of treatment of portacaval encephalopathy].
    Pirotte J
    Acta Gastroenterol Belg; 1971 Feb; 34(2):272-84. PubMed ID: 5565418
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the effects of total parenteral nutrition, continuous intragastric feeding, and portacaval shunt on a patient with type I glycogen storage disease.
    Burr IM; O'Neill JA; Karzon DT; Howard LJ; Greene HL
    J Pediatr; 1974 Dec; 85(6):792-5. PubMed ID: 4213651
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intrahepatic block without common cirrhosis].
    Fauvert R; Benhamou JP
    Acquis Med Recent; 1968; ():89-107. PubMed ID: 5742954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.